UK markets close in 5 hours 51 minutes

Koninklijke Philips N.V. (PHG)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
27.18-0.13 (-0.48%)
At close: 04:00PM EDT
26.99 -0.19 (-0.70%)
Pre-market: 05:36AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close27.31
Open27.24
Bid0.00 x 1200
Ask0.00 x 800
Day's range27.12 - 27.38
52-week range17.75 - 29.44
Volume951,807
Avg. volume1,209,980
Market cap25.793B
Beta (5Y monthly)0.69
PE ratio (TTM)N/A
EPS (TTM)-0.90
Earnings date29 Jul 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend date12 May 2022
1y target est22.65
  • GlobeNewswire

    Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients

    Woman wearing Philips ePatch Philips ePatch Dr. Jorge Pagola Val dHebron Philips Cardiologs AI analytics platform May 22, 2024 Philips wearable ePatch and AI analytics platform help detect potentially life-threatening irregular heartbeatsThe solution helps University Hospital Vall d’Hebron achieve reduced average length of stay, relieve emergency room pressure, and reduce costs Amsterdam, the Netherlands, and Madrid, Spain – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technol

  • Globe Newswire

    Philips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities

    Access to cardiac care in the Philippines Teleradiology in Argentina Mother and child health in the US May 21, 2024 Progress towards Philips Foundation’s 2030 target of 100 million lives improved in underserved communities each year17 new initiatives with strategic partners and 4 new investments in health tech enterprises that leverage Philips' expertise in early screening and diagnosis Strategy focused on building local ecosystems that provide reliable, sustainable solutions to healthcare deliv

  • Zacks

    Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data

    Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.